T2 Biosystems Q1 2024 GAAP EPS $(2.66) Misses $(2.27) Estimate, Sales $2.061M Beat $2.000M Estimate
T2 Biosystems Q1 2024 GAAP EPS $(2.66) Misses $(2.27) Estimate, Sales $2.061M Beat $2.000M Estimate
T2 Biosystems 2024年第一季度GAAP每股收益（2.66 美元）未达到预期（2.27）美元，销售额206.1万美元超过2,000万美元的预期
T2 Biosystems (NASDAQ:TTOO) reported quarterly losses of $(2.66) per share which missed the analyst consensus estimate of $(2.27) by 17.18 percent. This is a 97.98 percent increase over losses of $(132.00) per share from the same period last year. The company reported quarterly sales of $2.061 million which beat the analyst consensus estimate of $2.000 million by 3.05 percent. This is a 0.82 percent decrease over sales of $2.078 million the same period last year.
T2 Biosystems（纳斯达克股票代码：TTOO）公布的季度亏损为每股2.66美元，比分析师普遍预期的2.27美元（2.27美元）低17.18％。这比去年同期每股亏损132.00美元（132.00）增长了97.98％。该公司公布的季度销售额为206.1万美元，比分析师普遍预期的200万美元高出3.05％。这比去年同期的207.8万美元销售额下降了0.82％。